Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B- chronic lymphocytic leukaemia cells

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 142-146

  Bellosillo, Beatriz ^a,b   Colomer, Dolors ^b   Pons, Gabriel ^a   Gil, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Apoptosis; B CLL; Cytotoxicity; Mitoxantrone; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE INHIBITOR; FLUDARABINE; MITOXANTRONE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DNA CLEAVAGE; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; APOPTOSIS; B-LYMPHOCYTES; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; MITOXANTRONE;

EID: 0031982877     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00520.x     Document Type: Article

References (35)

1. Beck, J., Niethammer, D. & Gekeler, V. (1994) High mdr1- and mrp-, but low topoisomerase IIα-gene expression in B-cell chronic lymphocytic leukemias. Cancer Letters, 86, 135-142.
2. Beck, J., Niethammer, D. & Gekeler, V. (1996) MDR1, MRP, topoisomerase IIα/β, and cyclin A gene expression in acute and chronic leukemias. Leukemia, 10, (Suppl. 3), S39-S45.
3. Begleiter, A., Lee, K., Israels, L.G., Mowat, M.R.A. & Johnston, J.B. (1994) Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. Leukemia, 8, (Suppl. 1), S103-S106.
4. Bellosillo, B., Dalmau, M., Colomer, D. & Gil, J. (1997) Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. Blood, 89, 3378-3384.
5. Bhalla, K., Ibrado, A.M., Tourkina, E., Tang, C., Grant, S., Bullock, G., Huang, Y., Ponnathpur, V. & Mahoney, M.E. (1993) High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood, 82, 3133-3140.
6. Bosanquet, A.G. & Bell, P.B. (1996) Enhanced ex vivo drug sensitivity testing of chronic lymphocytic leukemia using refined DiSC assay methodology. Leukemia Research, 20, 143-153.
7. Canal, P., Attal, M., Chatelut, E., Guichard, S., Huguet, F., Muller, C., Schlaifer, D., Laurent, G., Houin, G. & Bugat, R. (1993) Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas. Cancer Research, 53, 4850-4854.
8. Carballo, E., Colomer, D., Vives Corrons, J.L., Blackshear P.J. & Gil J. (1996) Characterization and purification of a protein kinase C substrate in human B cells. Journal of Immunology, 156, 1709-1713.
9. Carrera, C.J., Piro, L.D., Saven, A., Beutler, E., Terai, C. & Carson, D.A. (1991) 2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes. Advances in Experimental Medicine and Biology, 309A, 15-18.
10. Chung, T.D.Y., Drake, F.H., Tan, K.B., Per, S.R., Crooke, S.T. & Mirabelli, C.K. (1989) Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proceedings of the National Academy of Sciences of the United States of America, 86, 9431-9435.
11. Drake, F.H., Hofmann, G.A., Bartus, H.F., Mattern, M.R., Crooke, S.T. & Mirabelli, C.K. (1989) Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry, 28, 8154-8160.
12. Foon, K.A., Rai, K.R. & Gale, R.P. (1990) Chronic lymphocytic leukemia: new insights into biology and therapy. Annals of Internal Medicine, 113, 525-539.
13. French Cooperative Group on Chronic Lymphocytic Leukemia (1986) Effectiveness of 'CHOP' regimen in advanced untreated chronic lymphocytic leukaemia. Lancet, i, 1346-1349.
14. French Cooperative Group on Chronic Lymphocytic Leukemia (1989) Long-term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. British Journal of Haematology, 73, 334-340.
15. Gale, R.P., Caligaris-Cappio, F., Dighiero, G., Keating, M., Montserrat, E. & Rai, K. (1994) Recent progress in chronic lymphocytic leukemia. Leukemia, 8, 1610-1614.
16. Harker, W.G., Slade, D.L., Drake, F.H. & Parr, R.L. (1991) Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase IIβ isoform. Biochemistry, 30, 9953-9961.
17. Hochhauser, D. & Harris, A.L. (1993) The role of topoisomerase IIα and IIβ in drug resistance. Cancer Treatment Reviews, 19, 181-194.
18. Kirkpatrick, D.L., Duke, M. & Goh, T.S. (1990) Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leukemia Research, 14, 459-468.
19. Krammer, P.H., Behrmann, I., Daniel, P., Dhein, J. & Debatin, K.M. (1994) Reguiation of apoptosis in the immune system. Current Opinion in Immunology, 6, 279-289.
20. Liu, L.F. (1989) DNA topoisomerase poisons as antitumor drugs. Annual Review of Biochemistry, 58, 351-375.
21. McConkey, D.J., Aguilar-Santelises, M., Hartzell, P., Eriksson, I., Mellstedt, H., Orrenius, S. & Jondal, M. (1991) Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. Journal of Immunology, 146, 1072-1076.
22. McConkey, D.J., Chandra, J., Wright, S., Plunkett, W., McDonnell, T.J., Reed, J.C. & Keating, M. (1996) Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. Journal of Immunology, 156, 2624-2630.
23. McKenna, S.L. & Padua, R.A. (1997) Multidrug resistance in leukaemia. British Journal of Haematology, 96, 659-674.
24. McKenna, S.L., Whittaker, J.A., Padua, R.A. & Holmes, J.A. (1993) Topoisomerase II expression in normal hemopoietic cells and chronic lymphocytic leukemia: drug sensitivity or resistance? Leukemia, 7, 1199-1203.
25. Mentz, F., Mossalayi, M.D., Ouaaz, K. Baudet, S., Issaly, F., Ktorza, S., Semichon, M., Binet, J.L. & Merle-Beral, H. (1996) Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood, 88, 2172-2182.
26. Montserrat, E. & Rozman, C. (1995) Chronic lymphocytic leukemia: present status. Annals of Oncology, 6, 219-235.
27. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
28. Potmesil, M., Hsiang, Y.H., Liu, L.F., Bank, B., Grossberg, H., Kirschenbaum, S., Forlenzar, T.J., Penziner, A., Kanganis, D., Knowles, D., Traganos, F. & Silber, R. (1988) Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. Cancer Research, 48, 3537-3543.
29. Robertson, L.E., Chubb, S., Meyn, R.E., Story, M., Ford, R., Hittelman, W.N. & Plunkett, W. (1993) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine. Blood, 81, 143-150.
30. Rozman, C. & Montserrat, E. (1995) Chronic lymphocytic leukemia. New England Journal of Medicine, 333, 1052-1057.
31. Silber, R., Degar, B., Costin, D., Newcomb, E.W., Mani, M., Rosenberg, C.R., Morse, L., Drygas, J.C., Canellakis, Z.N. & Potmesil, M. (1994) Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood, 84, 3440-3446.
32. Thomas, A., El Rouby, S., Reed, J.C., Krajewski, S., Silber, R., Potmesil, M. & Newcomb, E.W. (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene, 12, 1055-1062.
33. Twentyman, P.R., Fox, N.E. & Rees, J.K.H. (1989) Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. British Journal of Haematology, 71, 19-24.
34. Veerman, A.J.P. & Pieters, R. (1990) Drug sensitivity assays in leukaemia and lymphoma. British Journal of Haematology, 74, 381-384.
35. Wyllie, A.H., Kerr, J.F. & Currie, A.R. (1980) Cell death: the significance of apoptosis. International Review of Cytology, 68, 251-306.